Make It Ten №5 is with Christian Wandersee, CEO of the most recent investment of our CV IV fund: vasopharm. Hopefully, as a private person, you will never have to deal with the product vasopharm is developing, but if you do, it might save your life. vasopharm develops a novel treatment for traumatic brain injury.
Christian, please introduce vasopharm in one sentence.
vasopharm is the leading pharmaceutical company focusing on drug development in the indication of Traumatic Brain Injury (TBI).
Follow this link to read the complete interview on our Medium blog.